doi: 10.1212/01.wnl.0000113747.18760.d2.
Incidence and predictors for chronicity of headache in patients with episodic migraine
Affiliations
- PMID:15007133
- DOI: 10.1212/01.wnl.0000113747.18760.d2
Item in Clipboard
Incidence and predictors for chronicity of headache in patients with episodic migraine
Z Katsarava et al. Neurology..
Display options
Format
Display options
Format
Abstract
The authors followed 532 consecutive patients with episodic migraine (<15 days/month) for 1 year. Sixty-four patients (14%) developed chronic headache (>/=15 days/month). The odds ratios for developing CH were 20.1 (95% CI 5.7 to 71.5) comparing patients with a "critical" (10 to 14 days/month) vs "low" (0 to 4 days/month) and 6.2 (95% CI 1.7 to 26.6) in patients with an "intermediate" (6 to 9 days/month) vs "low" headache frequency and 19.4 (95% CI 8.7 to 43.2) comparing patients with and without medication overuse.
Similar articles
- Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB.Bigal ME, et al.Cephalalgia. 2004 Jun;24(6):483-90. doi: 10.1111/j.1468-2982.2004.00691.x.Cephalalgia. 2004.PMID:15154858
- Family history for chronic headache and drug overuse as a risk factor for headache chronification.Cevoli S, Sancisi E, Grimaldi D, Pierangeli G, Zanigni S, Nicodemo M, Cortelli P, Montagna P.Cevoli S, et al.Headache. 2009 Mar;49(3):412-8. doi: 10.1111/j.1526-4610.2008.01257.x.Headache. 2009.PMID:19267785
- Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate.Silberstein S, Diener HC, Lipton R, Goadsby P, Dodick D, Bussone G, Freitag F, Schwalen S, Ascher S, Morein J, Greenberg S, Biondi D, Hulihan J.Silberstein S, et al.Headache. 2008 Jul;48(7):1087-95. doi: 10.1111/j.1526-4610.2008.01185.x.Headache. 2008.PMID:18687081Review.
- Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache.Limmroth V, Biondi D, Pfeil J, Schwalen S.Limmroth V, et al.Headache. 2007 Jan;47(1):13-21. doi: 10.1111/j.1526-4610.2007.00648.x.Headache. 2007.PMID:17355489Clinical Trial.
- Tracing transformation: chronic migraine classification, progression, and epidemiology.Lipton RB.Lipton RB.Neurology. 2009 Feb 3;72(5 Suppl):S3-7. doi: 10.1212/WNL.0b013e3181974b19.Neurology. 2009.PMID:19188564Review.
Cited by
- The Neuroprotective Role of Indole-3-Propionic Acid in Migraine Pathophysiology.Agircan D, Taskin S, Cekic M, Celik H.Agircan D, et al.Medicina (Kaunas). 2024 Aug 30;60(9):1417. doi: 10.3390/medicina60091417.Medicina (Kaunas). 2024.PMID:39336458Free PMC article.
- Iron accumulation in deep brain nuclei in migraine: a population-based magnetic resonance imaging study.Kruit MC, Launer LJ, Overbosch J, van Buchem MA, Ferrari MD.Kruit MC, et al.Cephalalgia. 2009 Mar;29(3):351-9. doi: 10.1111/j.1468-2982.2008.01723.x. Epub 2008 Nov 19.Cephalalgia. 2009.PMID:19025553Free PMC article.
- Defining the differences between episodic migraine and chronic migraine.Katsarava Z, Buse DC, Manack AN, Lipton RB.Katsarava Z, et al.Curr Pain Headache Rep. 2012 Feb;16(1):86-92. doi: 10.1007/s11916-011-0233-z.Curr Pain Headache Rep. 2012.PMID:22083262Free PMC article.Review.
- The Chronic Migraine Brain: What Have We Learned From Neuroimaging?Filippi M, Messina R.Filippi M, et al.Front Neurol. 2020 Jan 9;10:1356. doi: 10.3389/fneur.2019.01356. eCollection 2019.Front Neurol. 2020.PMID:31998217Free PMC article.Review.
- Migraine incidence in 5 years: a population-based prospective longitudinal study in Turkey.Baykan B, Ertas M, Karlı N, Uluduz D, Uygunoglu U, Ekizoglu E, Kocasoy Orhan E, Saip S, Zarifoglu M, Siva A.Baykan B, et al.J Headache Pain. 2015;16:103. doi: 10.1186/s10194-015-0589-2. Epub 2015 Dec 3.J Headache Pain. 2015.PMID:26634568Free PMC article.Clinical Trial.
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Medical